RET receptor signaling: Function in development, metabolic disease, and cancer
Proceedings of the Japan Academy, Series B · 11.03.2022 · 98 (3) · 112-125
DOI: 10.2183/pjab.98.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Proceedings of the Japan Academy, Series B, erschienen am 11.03.2022. Verfasst von Masahide Takahashi. Beteiligte Einrichtung: International Center for Cell and Gene Therapy, Fujita Health University. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Metabolic Diseases. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Center for Cell and Gene Therapy, Fujita Health University.
- Department of Pathology, Nagoya University Graduate School of Medicine.
Zitieren
APA
Takahashi, M. (2022). RET receptor signaling: Function in development, metabolic disease, and cancer. Proceedings of the Japan Academy, Series B, 98(3), 112-125. https://doi.org/10.2183/pjab.98.008
Vancouver
Takahashi M. RET receptor signaling: Function in development, metabolic disease, and cancer. Proceedings of the Japan Academy, Series B. 2022;98(3):112-125. doi:10.2183/pjab.98.008
BibTeX
@article{Takahashi2022,
author = {Takahashi, Masahide},
title = {RET receptor signaling: Function in development, metabolic disease, and cancer},
journal = {Proceedings of the Japan Academy, Series B},
year = {2022},
volume = {98},
number = {3},
pages = {112--125},
doi = {10.2183/pjab.98.008}
}
EUVIMED